Correction: Milrinone Relaxes Pulmonary Veins in Guinea Pigs and Humans (PLoS ONE (2014) 9, 1 (e87685) DOI: 10.1371/journal.pone.0087685);Milrinone relaxes pulmonary veins in guinea pigs and humans

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  Rieg, Annette D ^a   Suleiman, Said ^a   Perez Bouza, Alberto ^a,b   Braunschweig, Till ^a   Spillner, Jan W ^a   Schrod̈er, Thomas ^c   Verjans, Eva ^a   Schal̈te, Gereon ^a   Rossaint, Rolf ^a   Uhlig, Stefan ^a   Martin, Christian ^a  

^a RWTH AACHEN UNIVERSITY   (Germany)

^b UNIVERSITY OF BONN   (Germany)

^c Medizinische Klinik Luisenhospital   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

9 (TETRAHYDRO 2 FURYL)ADENINE; ADENOSINE TRIPHOSPHATE SENSITIVE POTASSIUM CHANNEL; CYCLIC AMP; KT 5720; KT 5823; LARGE CONDUCTANCE CALCIUM ACTIVATED POTASSIUM CHANNEL; MILRINONE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; POTASSIUM CHANNEL;

ANIMAL TISSUE; ARTICLE; CAPILLARY RESISTANCE; CONTROLLED STUDY; DRUG MECHANISM; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE ACTIVATION; GUINEA PIG; HEART DISEASE; HEART MUSCLE RELAXATION; HUMAN; HUMAN TISSUE; HYDROSTATIC PRESSURE; ISOLATED PERFUSED LUNG; LUNG CANCER; LUNG EDEMA; LUNG LOBECTOMY; LUNG SLICE; NONHUMAN; ORGAN PERFUSION; PRECISION CUT LUNG SLICE; PULMONARY HYPERTENSION; PULMONARY VEIN; PULMONARY VENOUS OCCLUSIVE DISEASE; VASCULAR RESISTANCE; VIDEO MICROSCOPY;

ANIMALS; FEMALE; GUINEA PIGS; HUMANS; LARGE-CONDUCTANCE CALCIUM-ACTIVATED POTASSIUM CHANNELS; MALE; MILRINONE; ORGAN CULTURE TECHNIQUES; PHOSPHODIESTERASE 3 INHIBITORS; PULMONARY EDEMA; PULMONARY VEINS; VASCULAR RESISTANCE; VASODILATION;

EID: 84900331474     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0097207     Document Type: Erratum

References (56)

1. Adir Y, Offer A (2012) Pulmonary hypertension associated with left heart disease. Eur Respir Monogr 57: 119-137.
2. McLaughlin VV, Archer SL, Badesch DB, Barst RJ, Farber HW, et al. (2009) ACCF/AHA 2009 expert consensus document on pulmonary hypertension a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association developed in collaboration with the American College of Chest Physicians; American Thoracic Society, Inc.; and the Pulmonary Hypertension Association. J Am Coll Cardiol 53: 1573-1619. S0735-1097(09)00142-9 [pii];10.1016/j.jacc.2009.01.004 [doi].
3. Dadfarmay S, Berkowitz R, Kim B, Manchikalapudi RB (2010) Differentiating pulmonary arterial and pulmonary venous hypertension and the implications for therapy. Congest Heart Fail 16: 287-291. 10.1111/j.1751-7133.2010.00192.x [doi].
4. Guazzi M, Galie N (2012) Pulmonary hypertension in left heart disease. Eur Respir Rev 21: 338-346. 21/126/338 [pii];10.1183/09059180.00004612 [doi].
5. Price LC, Wort SJ, Finney SJ, Marino PS, Brett SJ (2010) Pulmonary vascular and right ventricular dysfunction in adult critical care: current and emerging options for management: a systematic literature review. Crit Care 14: R169. cc9264 [pii];10.1186/cc9264 [doi].
6. Nolan J, Sanderson A, Taddei F, Smith S, Muir AL (1992) Acute effects of intravenous phosphodiesterase inhibition in chronic heart failure: simultaneous pre- and afterload reduction with a single agent. Int J Cardiol 35: 343-349.
7. Hentschel T, Yin N, Riad A, Habbazettl H, Weimann J, et al. (2007) Inhalation of the phosphodiesterase-3 inhibitor milrinone attenuates pulmonary hypertension in a rat model of congestive heart failure. Anesthesiology 106: 124-131. 00000542-200701000-00021 [pii].
8. Lakshminrusimha S, Porta NF, Farrow KN, Chen B, Gugino SF, et al. (2009) Milrinone enhances relaxation to prostacyclin and iloprost in pulmonary arteries isolated from lambs with persistent pulmonary hypertension of the newborn. Pediatr Crit Care Med 10: 106-112.
9. Piamsomboon C, Tanaka KA, Szlam F, Makita T, Huraux C, et al. (2007) Comparison of relaxation responses to multiple vasodilators in TxA(2)-analog and endothelin-1-precontracted pulmonary arteries. Acta Anaesthesiol Scand 51: 714-721. (Pubitemid 46918553)
10. Rossing TH, Drazen JM (1986) Effects of milrinone on contractile responses of guinea pig trachea, lung parenchyma and pulmonary artery. J Pharmacol Exp Ther 238: 874-879. (Pubitemid 16033222)
11. Wagner RS, Smith CJ, Taylor AM, Rhoades RA (1997) Phosphodiesterase inhibition improves agonist-induced relaxation of hypertensive pulmonary arteries. J Pharmacol Exp Ther 282: 1650-1657. (Pubitemid 27408352)
12. Kato R, Sato J, Nishino T (1998) Milrinone decreases both pulmonary arterial and venous resistances in the hypoxic dog. Br J Anaesth 81: 920-924. (Pubitemid 28561327)
13. Gao Y, Raj JU (2005) Role of veins in regulation of pulmonary circulation. Am J Physiol Lung Cell Mol Physiol 288: L213-L226. 288/2/L213 [pii];10.1152/ajplung.00103.2004 [doi].
14. Zhuang FY, Fung YC, Yen RT (1983) Analysis of blood flow in cat's lung with detailed anatomical and elasticity data. J Appl Physiol 55: 1341-1348. (Pubitemid 13021828)
15. Ressmeyer A, Larsson A, Vollmer E, Dahlen S, Uhlig S, et al. (2006) Characterisation of guinea pig precision-cut lung slices: comparison with human tissues. Eur Respir J 28: 603-611. (Pubitemid 44794677)
16. Schleputz M, Rieg AD, Seehase S, Spillner J, Perez-Bouza A, et al. (2012) Neurally Mediated Airway Constriction in Human and Other Species: A Comparative Study Using Precision-Cut Lung Slices (PCLS). PLoS One 7: e47344. 10.1371/journal.pone.0047344 [doi];PONE-D-12-11366 [pii].
17. Rieg AD, Rossaint R, Uhlig S, Martin C (2011) Cardiovascular agents affect the tone of pulmonary arteries and veins in precision-cut lung slices. PLoS One 6: e29698. 10.1371/journal.pone.0029698 [doi];PONE-D-11-15270 [pii].
18. Uhlig S, Wollin L (1994) An improved setup for the isolated perfused rat lung. J Pharmacol Toxicol Methods 31: 85-94. (Pubitemid 24161762)
19. Atzori L, Bannenberg G, Corriga AM, Moldeus P, Ryrfeldt A (1992) Sulfur dioxide-induced bronchoconstriction in the isolated perfused and ventilated guinea-pig lung. Respiration 59: 16-21.
20. Horgan MJ, Pinheiro JM, Malik AB (1991) Mechanism of endothelin-1-induced pulmonary vasoconstriction. Circ Res 69: 157-164.
21. ATP-channels, cAMP and cGMP. PLoS ONE 8(6): e66195 doi:101371/journal pone 0066195.
22. Schneider MP, Boesen EI, Pollock DM (2007) Contrasting actions of endothelin ET(A) and ET(B) receptors in cardiovascular disease. Annu Rev Pharmacol Toxicol 47: 731-759.
23. Rossi P, Persson B, Boels PJ, Arner A, Weitzberg E, et al. (2008) Endotoxemic pulmonary hypertension is largely mediated by endothelin-induced venous constriction. Intensive Care Med 34: 873-880. 10.1007/s00134-007-0980-9 [doi]. (Pubitemid 351571188)
24. Feletou M, Girard V, Canet E (1995) Different involvement of nitric oxide in endothelium-dependent relaxation of porcine pulmonary artery and vein: influence of hypoxia. J Cardiovasc Pharmacol 25: 665-673.
25. Shi W, Wang C, Dandurand R, Eidelman D, Michel R (1998) Differential responses of pulmonary arteries and veins to histamine and 5-HT in lung explants of guinea-pigs. Br J Pharmacol 123: 1525-1532. (Pubitemid 28182034)
26. Shirai M, Ikeda S, Min KY, Shimouchi A, Kawaguchi AT, et al. (1999) Segmental differences in vasodilatation due to basal NO release in in vivo cat pulmonary vessels. Respir Physiol 116: 159-169. (Pubitemid 29361440)
27. Kemp BK, Smolich JJ, Cocks TM (1997) Evidence for specific regional patterns of responses to different vasoconstrictors and vasodilators in sheep isolated pulmonary arteries and veins. Br J Pharmacol 121: 441-450. 10.1038/sj.bjp.0701058 [doi]. (Pubitemid 27226296)
28. Boswell-Smith V, Spina D, Page CP (2006) Phosphodiesterase inhibitors. Br J Pharmacol 147 Suppl 1: S252-S257. 0706495 [pii];10.1038/sj.bjp.0706495 [doi].
29. Taylor MS, Benoit JN (1999) Effect of milrinone on small mesenteric artery vasoconstriction: role of K(+) channels. Am J Physiol 277: G69-G78. (Pubitemid 29352647)
30. van der Zypp A, Rechtman M, Majewski H (2000) The role of cyclic nucleotides and calcium in the relaxation produced by amrinone in rat aorta. Gen Pharmacol 34: 245-253. S0306362300000719 [pii].
31. Kauffman RF, Schenck KW, Utterback BG, Crowe VG, Cohen ML (1987) In vitro vascular relaxation by new inotropic agents: relationship to phosphodiesterase inhibition and cyclic nucleotides. J Pharmacol Exp Ther 242: 864-872. (Pubitemid 17156526)
32. Jiang H, Colbran JL, Francis SH, Corbin JD (1992) Direct evidence for cross-activation of cGMP-dependent protein kinase by cAMP in pig coronary arteries. J Biol Chem 267: 1015-1019.
33. Kostic TS, Tomic M, Andric SA, Stojilkovic SS (2002) Calcium-independent and cAMP-dependent modulation of soluble guanylyl cyclase activity by G protein-coupled receptors in pituitary cells. J Biol Chem 277: 16412-16418. (Pubitemid 34967652)
34. Morgado M, Cairrao E, Santos-Silva AJ, Verde I (2012) Cyclic nucleotide-dependent relaxation pathways in vascular smooth muscle. Cell Mol Life Sci 69: 247-266.
35. Pelligrino DA, Wang Q (1998) Cyclic nucleotide crosstalk and the regulation of cerebral vasodilation. Prog Neurobiol 56: 1-18. (Pubitemid 28351159)
36. Bender AT, Beavo JA (2006) Cyclic nucleotide phosphodiesterases: molecular regulation to clinical use. Pharmacol Rev 58: 488-520. 58/3/488 [pii];10.1124/pr.58.3.5 [doi].
37. Lubomirov LT, Schubert R, Gagov HS, Duridanova DB, Pfitzer G (2006) Urocortin decreases phosphorylation of MYPT1 and increases the myosin phosphatase activity via elevation of the intracellular level of cAMP. Biofizika 51: 773-780.
38. Ko EA, Han J, Jung ID, Park WS (2008) Physiological roles of K+ channels in vascular smooth muscle cells. J Smooth Muscle Res 44: 65-81.
39. Nelson MT, Quayle JM (1995) Physiological roles and properties of potassium channels in arterial smooth muscle. Am J Physiol 268: C799-C822.
40. Michelakis ED, Weir EK, Wu X, Nsair A, Waite R, et al. (2001) Potassium channels regulate tone in rat pulmonary veins. Am J Physiol Lung Cell Mol Physiol 280: L1138-L1147.
41. Zhu S, White RE, Barman SA (2008) Role of phosphodiesterases in modulation of BKCa channels in hypertensive pulmonary arterial smooth muscle. Ther Adv Respir Dis 2: 119-127. 2/3/119 [pii];10.1177/1753465808091327 [doi].
42. Muir AL, Nolan J (1991) Modulation of venous tone in heart failure. Am Heart J 121: 1948-1950.
43. Kuebler WM, Yang Y, Samapati R, Uhlig S (2010) Vascular barrier regulation by PAF, ceramide, caveolae, and NO - an intricate signaling network with discrepant effects in the pulmonary and systemic vasculature. Cell Physiol Biochem 26: 29-40.
44. Evans A, Hardie D, Peers C, Mahmoud A (2011) Hypoxic pulmonary vasoconstriction: mechanisms of oxygen-sensing. Curr Opin Anaesthesiol 24: 13-20.
45. Lee TS, Hou X (1995) Comparative vasoactive effects of amrinone on systemic and pulmonary arteries in rabbits. Chest 108: 1364-1367.
46. Shaul PW, Muntz KH, Buja LM (1990) Comparison of beta adrenergic receptor binding characteristics and coupling to adenylate cyclase in rat pulmonary artery versus aorta. J Pharmacol Exp Ther 252: 86-92. (Pubitemid 20067697)
47. el-Kashef HA, Catravas JD (1990) Effects of arachidonic acid in the rabbit pulmonary and systemic vascular beds in vivo. Pharmacology 40: 60-68.
48. McIntyre Jr RC, Sheridan B, Agrafojo J, Fullerton DA (1997) Endotoxin differentially impairs cyclic guanosine monophosphate-mediated relaxation in the pulmonary and systemic circulations. Crit Care Med 25: 318-323. (Pubitemid 27086070)
49. Pulido EJ, Shames BD, Fullerton DA, Sheridan BC, Selzman CH, et al. (2000) Differential inducible nitric oxide synthase expression in systemic and pulmonary vessels after endotoxin. Am J Physiol Regul Integr Comp Physiol 278: R1232-R1239. (Pubitemid 30366452)
50. Chaliki HP, Hurrell DG, Nishimura RA, Reinke RA, Appleton CP (2002) Pulmonary venous pressure: relationship to pulmonary artery, pulmonary wedge, and left atrial pressure in normal, lightly sedated dogs. Catheter Cardiovasc Interv 56: 432-438. 10.1002/ccd.10203 [doi]. (Pubitemid 34693905)
51. Montani D, Price L, Dorfmuller P, Achouh L, Jais X, et al. (2009) Pulmonary veno-occlusive disease. Eur Respir J 33: 189-200.
52. Raj JU, Ramanathan R, Chen P, Anderson J (1989) Effect of hematocrit on microvascular pressures in 3- to 5-wk-old rabbit lungs. Am J Physiol 256: H766-H771.
53. Baruch L, Patacsil P, Hameed A, Pina I, Loh E (2001) Pharmacodynamic effects of milrinone with and without a bolus loading infusion. Am Heart J 141: 266-273. S0002-8703(01)07029-6 [pii];10.1067/mhj.2001.111404 [doi].
54. Ramamoorthy C, Anderson GD, Williams GD, Lynn AM (1998) Pharmacokinetics and side effects of milrinone in infants and children after open heart surgery. Anesth Analg 86: 283-289. (Pubitemid 28079476)
55. Christman BW, McPherson CD, Newman JH, King GA, Bernard GR, et al. (1992) An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension. N Engl J Med 327: 70-75.
56. Hourani SM, Boon K, Fooks HM, Prentice DJ (2001) Role of cyclic nucleotides in vasodilations of the rat thoracic aorta induced by adenosine analogues. Br J Pharmacol 133: 833-840. (Pubitemid 32751792)